The RAD51 135G>C polymorphism is related to the effect of adjuvant therapy in early breast cancer. [electronic resource]
Producer: 20150622Description: 797-804 p. digitalISSN:- 1432-1335
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Breast Neoplasms -- drug therapy
- Chemotherapy, Adjuvant
- Cyclophosphamide -- administration & dosage
- Cytosine
- Female
- Fluorouracil -- administration & dosage
- Gene Expression Regulation, Neoplastic
- Genetic Predisposition to Disease
- Genotype
- Guanine
- Humans
- Mastectomy, Segmental
- Methotrexate -- administration & dosage
- Middle Aged
- Neoplasm Recurrence, Local -- prevention & control
- Polymerase Chain Reaction -- methods
- Polymorphism, Restriction Fragment Length
- Polymorphism, Single Nucleotide
- Predictive Value of Tests
- Prognosis
- Rad51 Recombinase -- genetics
- Radiotherapy, Adjuvant
- Sequence Analysis, DNA
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.